Comparing two methods for treating fluid buildup in the lungs due to liver disease
Official title: Comparing Outcome of Thoracocentesis and Pigtail Catheter Drainage in Treatment of Patients With Hepatic Hydrothorax
Run by Sohag University · NCT06319547 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing which method, between thoracocentesis and pigtail catheter drainage, works better to treat fluid buildup in the lungs for people with liver disease.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Sohag University Academic / other |
| Locations | 1 site (Sohag) |
| Trial ID | NCT06319547 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients diagnosed with liver cirrhosis who also have hepatic hydrothorax.
✕Probably not a fit
Patients with pleural effusions caused by conditions other than hepatic hydrothorax will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study compares the effectiveness of thoracocentesis and pigtail catheter drainage in treating patients with hepatic hydrothorax, a condition where fluid accumulates in the pleural cavity due to liver cirrhosis. The trial aims to determine which method provides better outcomes for patients suffering from this complication. Participants will be selected based on specific criteria related to their liver condition and the nature of their pleural effusion. The study is conducted at Sohag University hospitals, focusing on patients with liver cirrhosis and hepatic hydrothorax.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment options for patients with hepatic hydrothorax, enhancing their quality of life.
How similar studies have gone: While there have been studies on pleural effusions, this specific comparison of thoracocentesis and pigtail catheter drainage in hepatic hydrothorax is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who met the following inclusion criteria were enrolled: * Liver cirrhosis (with or without hepatocellular carcinoma). * Hepatic hydrothorax (bilateral or unilateral). Exclusion Criteria: * patients with a pleural effusion due to a condition other than HH. * who had a diagnosis of tuberculosis pleurisy, parapneumonic effusion, inflammatory pleuritis, other neoplasms, and congestive heart failure.
Where it's running
-
Sohag University hospitals
Sohag, Egypt Recruiting
Study contacts
- Study coordinator: Aya A AbdElkareem, Resident
- Email: ayah.ashraf@med.sohag.edu.eg
- Phone: 01060342951
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Trauma registry at Sohag University Hospital
This study tests the creation of a trauma registry in the emergency department to collect data on injured adults admitted with polytrauma at Sohag University Hospital.
-
Prevalence of Myocardial Bridging and its relation to Coronary Plaques on MDCT
This study tests how common myocardial bridging is and whether it relates to coronary plaque in patients undergoing coronary CT angiography.
-
Septoplasty: see if it changes headache symptoms
This study tests whether septoplasty can change headache severity in adults with septal deviation and headache.
-
Predicting SLE Flares with Patient Reports and Machine Learning
Aims to test a low-cost, patient-reported outcome–based machine learning tool to see if it can detect lupus flares early and support care, especially in settings with limited resources.
-
Is geographic mismatch linked to short-term major heart problems after long drug-eluting stent placement?
This study checks whether geographic mismatch can predict short-term major adverse cardiovascular events after a long drug-eluting stent is placed in the coronary arteries.
-
Biomarkers to predict no-reflow after opening the heart’s artery in STEMI patients
This study tests whether immune-inflammatory and metabolic biomarkers can predict coronary no-reflow after primary PCI in adults with STEMI.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.